ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

AbbVie at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

AbbVie takes part in 2 sessions at ESMO 2026 in Madrid, and exhibits at Booth 8034. Its work spans personalised care in ovarian cancer and drug combinations in non-small-cell lung cancer. One study examines how osimertinib affects the movement of telisotuzumab vedotin inside cancer cells.

OrganizationESMO 2026 Attendance
AbbVie
North Chicago, IL
Large pharmaExhibitor
Global biopharmaceutical company with oncology medicines including venetoclax, ibrutinib and antibody-drug conjugates.
Booth
Exhibiting at Booth 8034
Satellite
Fri Oct 23
09:45–11:15
AbbVie - Riding the Wave of Innovation Towards Personalized Medicine in Ovarian Cancer
Sponsored session · with Hospital Universitario Puerta de Hierro Majadahonda
Gynaecological cancers
Poster
Fri Oct 23
13:00–15:00

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at AbbVie

Tell us what you sell and we’ll find the people at AbbVie most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction